• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
  • Awards
    • CRO Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Pharma
    • Vaccines
    • Asia
    • Cell & Gene Therapy
    • Drug Delivery
    • Executives
  • Manufacturing
    • Facilities
    • Recalls
    • Warning Letters
  • Marketing
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Trending
    • Oncology
  • Awards
    • CRO Awards
    • Innovation Awards
    • Pharma Marketing Awards
  • Resources
    • Podcasts
    • Fierce Events
    • Industry Events
    • Webinars
    • Whitepapers
    • Survey
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

Spain

financials earnings profit profit miss earnings miss decline revenue decline
Manufacturing

Rovi warns analyst profit consensus is 10% to 15% too high

Spanish CDMO Rovi is part of a parade of biopharma contractors struggling to keep their manufacturing businesses growing in a post-COVID world.
Fraiser Kansteiner Feb 13, 2025 9:58am
turning down money rejecting money business offer

Grifols deflects private equity firm's potential takeover offer

Nov 20, 2024 10:13am
deal handshake business cooperation partnerships

Teva inks cancer biosimilar marketing pact with mAbxience

Apr 4, 2024 10:33am
Drug inspection FDA regulatory submission

EMA halts manufacturing after inspection of Serra Pamies plant

Aug 22, 2023 1:54pm
concept of job dismissal with puzzle pieces

Grifols is the latest drugmaker to succumb to the layoff trend

Feb 15, 2023 5:56pm
Drug inspection FDA regulatory submission

FDA hits Spanish drug substance maker Bioiberica with a Form 483

Jun 16, 2022 10:50am

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
  • Our Brands
    • Fierce Biotech
    • Fierce Healthcare
    • Fierce Pharma
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings